Prot #M16-047-AD Up: A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date1/31/191/31/23

Funding

  • AbbVie Inc. (Prot #M16-047-AD Up)